OLANZAPINE TEVA ® 15 MG

Land: Israel

Sprog: engelsk

Kilde: Ministry of Health

Aktiv bestanddel:

OLANZAPINE 15 MG

Tilgængelig fra:

SALOMON,LEVIN & ELSTEIN LTD

ATC-kode:

N05AH03

Lægemiddelform:

FILM COATED TABLETS

Indgivelsesvej:

PER OS

Fremstillet af:

TEVA OPERATIONS POLAND SP.ZO.O

Terapeutisk gruppe:

OLANZAPINE

Terapeutiske indikationer:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Autorisation dato:

2011-04-01